- Respiratory care devices are essential tools used in the diagnosis, monitoring, and treatment of respiratory conditions, providing critical support for patients suffering from diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. They include devices such as ventilators, oxygen concentrators, nebulizers, and continuous positive airway pressure (CPAP) machines
- The demand for these devices is significantly driven by the rising prevalence of respiratory disorders globally, technological advancements in portable and homecare solutions, and the growing aging population that is more susceptible to chronic respiratory diseases
- North America is expected to dominate the global respiratory care devices market with a market share of approximately 58.5%, driven by advanced healthcare infrastructure, widespread adoption of cutting-edge medical technologies, and the strong presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the respiratory care devices market with market share of 19.9%, driven by rapid expansion in healthcare infrastructure, increasing awareness about respiratory health, and rising patient volumes
- The therapeutic devices segment is expected to dominate the respiratory care devices market with the largest share of 58.5% in 2024 due to the increasing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea.
